MLICM
RSTI

Metropolitan Life Insurance Company (MetLife)’s Rofin-Sinar Technologies Inc RSTI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RSTI Stock Details RSTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,709
Closed -$634K – 2684
2016
Q3 		$634K Hold
19,709
– – ﹤0.01% 1550
2016
Q2 		$630K Hold
19,709
– – ﹤0.01% 1549
2016
Q1 		$635K Hold
19,709
– – ﹤0.01% 1441
2015
Q4 		$528K Hold
19,709
– – ﹤0.01% 1590
2015
Q3 		$511K Sell
19,709
-1,890
-9% -$48K ﹤0.01% 1618
2015
Q2 		$596K Sell
21,599
-2,037
-9% -$55K ﹤0.01% 1626
2015
Q1 		$573K Hold
23,636
– – ﹤0.01% 1483
2014
Q4 		$680K Sell
23,636
-342
-1% -$8.6K ﹤0.01% 1558
2014
Q3 		$553K Hold
23,978
– – ﹤0.01% 1659
2014
Q2 		$576K Hold
23,978
– – ﹤0.01% 1735
2014
Q1 		$575K Hold
23,978
– – ﹤0.01% 1711
2013
Q4 		$648K Hold
23,978
– – ﹤0.01% 1625
2013
Q3 		$581K Hold
23,978
– – ﹤0.01% 1657
2013
Q2 		$598K Buy
+23,978
New +$621K ﹤0.01% 1577

Metropolitan Life Insurance Company (MetLife)'s RSTI Position: Q4 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Rofin-Sinar Technologies Inc (RSTI) in Q4 2016, closing a stake of 19,709 shares — an estimated $634K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RSTI in Q2 2013 and held it in 14 quarters. The position peaked at $680K in Q4 2014. 0 funds tracked by Wall St. Rank hold RSTI as of Q4 2016.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Rofin-Sinar Technologies Inc position as of Q4 2016 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 19,709 Rofin-Sinar Technologies Inc shares in Q4 2016, an estimated $634K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Rofin-Sinar Technologies Inc in Q2 2013 and held it in 14 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Rofin-Sinar Technologies Inc position peaked at $680K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Rofin-Sinar Technologies Inc as of Q4 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2016, filed 14 Feb 2017.